PMID- 32400115 OWN - NLM STAT- MEDLINE DCOM- 20210809 LR - 20210809 IS - 1522-726X (Electronic) IS - 1522-1946 (Linking) VI - 96 IP - 7 DP - 2020 Dec TI - Effect of concomitant aortic regurgitation on early hypo-attenuated leaflet thickening after transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis. PG - 1491-1497 LID - 10.1002/ccd.28903 [doi] AB - OBJECTIVE: We hypothesize that different degree of pre-existing aortic regurgitation (AR) may affect the presence of hypo-attenuated leaflet thickening (HALT) after transcatheter aortic valve replacement (TAVR). BACKGROUND: The mechanism of the presence of HALT post-TAVR is not fully understood. METHODS: We retrospectively evaluated the post-procedural multi-slice computed tomography (MSCT) before discharge for evidence of HALT. Patients were grouped according to the degree of pre-existing AR. Baseline, native anatomy and procedure details were compared, then multivariate regression was performed. RESULTS: MSCT analyzed was performed at a median of 6 days post-TAVR in 179 patients. HALT was detected in 10.6% of patients. After adjusting for variables that were significantly different between groups, pre-existing >/= moderate AR was protective to the risk of HALT (OR 0.15, 95% CI 0.03-0.84, p = .03). Stratifying for factors that might explain the impact of pre-existing AR on HALT, patients with a small Sinus of Valsalva, non-eccentric remodeling and receiving a large bioprosthesis experienced a sevenfold higher risk for HALT (OR 7.16, 95% CI 2.05-25.08, p = .002). CONCLUSIONS: Patients underwent TAVR with pre-existing >/= moderate AR appeared to experience a lower incidence of early HALT compared to those patients with less than moderate AR, which may be explained by a larger Sinus of Valsalva and a higher proportion of LV eccentric remodeling. CI - (c) 2020 Wiley Periodicals, Inc. FAU - Xiong, Tian-Yuan AU - Xiong TY AUID- ORCID: 0000-0001-8054-3512 AD - Department of Cardiology, West China Hospital, Sichuan University, Chengdu, PR China. FAU - Liao, Yan-Biao AU - Liao YB AD - Department of Cardiology, West China Hospital, Sichuan University, Chengdu, PR China. FAU - Li, Yi-Jian AU - Li YJ AUID- ORCID: 0000-0002-3755-5961 AD - Department of Cardiology, West China Hospital, Sichuan University, Chengdu, PR China. FAU - Chen, Fei AU - Chen F AD - Department of Cardiology, West China Hospital, Sichuan University, Chengdu, PR China. FAU - Li, Xi AU - Li X AUID- ORCID: 0000-0002-3018-618X AD - Department of Cardiology, West China Hospital, Sichuan University, Chengdu, PR China. FAU - Wang, Zi-Jie AU - Wang ZJ AD - Department of Cardiology, West China Hospital, Sichuan University, Chengdu, PR China. FAU - Wang, Xi AU - Wang X AD - Department of Cardiology, West China Hospital, Sichuan University, Chengdu, PR China. FAU - Ou, Yuanweixiang AU - Ou Y AD - Department of Cardiology, West China Hospital, Sichuan University, Chengdu, PR China. FAU - Li, Qiao AU - Li Q AD - Department of Cardiology, West China Hospital, Sichuan University, Chengdu, PR China. FAU - Wei, Jia-Fu AU - Wei JF AD - Department of Cardiology, West China Hospital, Sichuan University, Chengdu, PR China. FAU - Peng, Yong AU - Peng Y AD - Department of Cardiology, West China Hospital, Sichuan University, Chengdu, PR China. FAU - Meng, Wei AU - Meng W AD - Department of Cardiovascular Surgery, West China Hospital, Sichuan University, Chengdu, PR China. FAU - Feng, Yuan AU - Feng Y AD - Department of Cardiology, West China Hospital, Sichuan University, Chengdu, PR China. FAU - Chen, Mao AU - Chen M AD - Department of Cardiology, West China Hospital, Sichuan University, Chengdu, PR China. LA - eng PT - Journal Article DEP - 20200513 PL - United States TA - Catheter Cardiovasc Interv JT - Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions JID - 100884139 SB - IM CIN - Catheter Cardiovasc Interv. 2020 Dec;96(7):1498-1499. PMID: 33306885 MH - Aged MH - Aged, 80 and over MH - Aortic Valve/diagnostic imaging/physiopathology/*surgery MH - Aortic Valve Insufficiency/diagnostic imaging/physiopathology/*surgery MH - Aortic Valve Stenosis/diagnostic imaging/physiopathology/*surgery MH - Female MH - Hemodynamics MH - Humans MH - Male MH - Retrospective Studies MH - Severity of Illness Index MH - Time Factors MH - *Transcatheter Aortic Valve Replacement/adverse effects MH - Treatment Outcome MH - Ventricular Function, Left MH - Ventricular Remodeling OTO - NOTNLM OT - aortic regurgitation OT - aortic stenosis OT - hypo-attenuated leaflet thickening OT - transcatheter aortic valve implantation EDAT- 2020/05/14 06:00 MHDA- 2021/08/10 06:00 CRDT- 2020/05/14 06:00 PHST- 2020/01/21 00:00 [received] PHST- 2020/03/12 00:00 [revised] PHST- 2020/03/30 00:00 [accepted] PHST- 2020/05/14 06:00 [pubmed] PHST- 2021/08/10 06:00 [medline] PHST- 2020/05/14 06:00 [entrez] AID - 10.1002/ccd.28903 [doi] PST - ppublish SO - Catheter Cardiovasc Interv. 2020 Dec;96(7):1491-1497. doi: 10.1002/ccd.28903. Epub 2020 May 13.